Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02851875 · ClinicalTrials.gov registry record
Duke Scleroderma Clinic Patient Registry
A clinical trial, sponsored by Duke University.
- Terminated
- Registry status
- 42
- Enrollment target
NCT02851875: Clinical Trial study, sponsored by Duke University.
NCT02851875 is a clinical trial that was terminated before completion, run by Duke University. The registered enrollment target is 42 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02851875 was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- 42 participants
- Enrollment target
Study Summary
The purpose of the Duke Scleroderma Registry (DSScR) is to obtain information about scleroderma. This information could be used in future research to increase the understanding of disease mechanisms, treatments, and outcomes. This research may also help develop new therapies, novel measures of disease assessment or identify previously unknown manifestations of the diseases. A prospectively followed cohort is an integral component of future translational and clinical research programs. A registry for scleroderma would allow for information to be gleaned about patients in "real-world situations" in an effort to improve the reality, generalizability and applicability of information gathered.
Primary Outcome
The Rodnan skin score is a discrete measure of skin thickness that can change through time and in response to medication.
Interventions
- OTHER Registry
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2016-04 |
| Est. Completion | 2018-05-07 |
Why NCT02851875 stopped before completion
NCT02851875 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 42 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Registry is the first listed.
NCT02851875 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02851875 about?
NCT02851875 is a clinical study titled "Duke Scleroderma Clinic Patient Registry". The purpose of the Duke Scleroderma Registry (DSScR) is to obtain information about scleroderma. This information could be used in future research to increase the understanding of disease mechanisms, treatments, and outcomes. This research may also help develop new therapies, novel measures of disea...
What is the current status of trial NCT02851875?
This trial is currently terminated. The enrollment target is 42 participants. The study started on 2016-04. Estimated completion is 2018-05-07.
What interventions are being tested in trial NCT02851875?
The interventions under investigation include: Registry (OTHER).
Who is sponsoring clinical trial NCT02851875?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia